Newer formulations are even more effective at preventing illnesses that commonly afflict seniors — perhaps even dementia.

A senior scientist at the US CDC has resigned, warning that changes in leadership may weaken the country’s vaccine program.

In advance of this week's CDC vaccine advisory meeting, HHS Secretary Robert F. Kennedy Jr. restacked the committee, claiming ...

RSV is the most common cause of hospitalization in babies, but Sanofi is one of a few companies producing a shot that can ...

The FDA has expanded the approval of mResvia to include active immunization in high-risk individuals 18 through 59 years of age.